Hoess R, Wierzbicki A, Abremski K
Experimental Station, E.I. Dupont de Nemours & Co., Wilmington, DE 19898.
Proc Natl Acad Sci U S A. 1987 Oct;84(19):6840-4. doi: 10.1073/pnas.84.19.6840.
Cre, the site-specific recombinase from bacteriophage P1, catalyzes a recombination reaction between specific DNA sequences designated as lox sites. The breakage and rejoining of partners during this recombination process must be highly concerted because it has not been possible to detect intermediates of the reaction with wild-type Cre. Several mutant Cre proteins have been isolated that produce significant amounts of a possible intermediate product of the recombination reaction. The product has been identified as a Holliday structure in which one set of the DNA strands of the recombining partners has been exchanged. Wild-type Cre protein is capable of acting on this structure to form recombinant products, which is consistent with this being an intermediate in the recombination reaction. Characterization of the Holliday structure indicated that one set of strands in the recombining partners was always exchanged preferentially before the other set. In addition, it has been found that certain Cre mutants that are unable to carry out recombination in vitro are able to resolve the intermediate. This suggests that these mutants are defective in a step in the reaction that precedes the formation of the Holliday intermediate.
来自噬菌体P1的位点特异性重组酶Cre催化特定DNA序列(称为lox位点)之间的重组反应。在这个重组过程中,伙伴之间的断裂和重新连接必须高度协调,因为用野生型Cre无法检测到反应中间体。已经分离出几种突变型Cre蛋白,它们会产生大量可能的重组反应中间产物。该产物已被鉴定为霍利迪结构,其中重组伙伴的一组DNA链已发生交换。野生型Cre蛋白能够作用于这种结构以形成重组产物,这与它是重组反应中的中间体一致。对霍利迪结构的表征表明,重组伙伴中的一组链总是比另一组优先发生交换。此外,还发现某些在体外无法进行重组的Cre突变体能够解析中间体。这表明这些突变体在霍利迪中间体形成之前的反应步骤中存在缺陷。